Qianqian Lin

Fujian Medical University — China

Medicine · Health Sciences

10h-index332citations26works8.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(9), CAR-T cell therapy research(7), Animal Virus Infections Studies(5), COVID-19 Clinical Research Studies(4), Air Quality and Health Impacts(4)

Publications26 total

Patients with lymphocytopenia derive no benefit from the treatment of methylprednisolone added to endovascular therapy: A secondary analysis of the MARVEL trial
Journal of the Neurological Sciences·2025
Breaking barriers: ECM-degrading CAR T cells for enhanced efficacy in solid tumors 4516
The Journal of Immunology·2025Open Access
Methylprednisolone as Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke Patients with a Large Infarct Core (MIRACLE): Protocol of a Randomized Trial
2025Open Access
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia
Blood·2025· 12 cited
Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicity
Science Advances·2025· 12 citedOpen Access
In vivo AAV–SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy
Nature Biotechnology·2024· 42 cited
Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b
BMC Cancer·2024· 3 citedOpen Access
Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation
Journal of Experimental & Clinical Cancer Research·2024· 6 citedOpen Access
Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy
2024Open Access
Visualization of Thromboinflammation by 18F-DPA-714 PET in a Stroke Patient
Clinical Nuclear Medicine·2023· 3 cited
AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells
Nature Biomedical Engineering·2023· 27 citedOpen Access
Perturbomics of tumor-infiltrating NK cells
2023· 5 citedOpen Access
Therapeutic immune cell engineering with an mRNA : AAV- <i>Sleeping Beauty</i> composite system
2023· 2 citedOpen Access
RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq
Cell chemical biology·2023· 6 citedOpen Access
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Cell Discovery·2022· 7 citedOpen Access
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
Cell Reports·2022· 23 citedOpen Access
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Nature Communications·2022· 56 citedOpen Access
Simultaneous and sequential multi-species coronavirus vaccination
2022· 1 citedOpen Access
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
Cell Reports Medicine·2022· 19 citedOpen Access
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
2022· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sidi Chen(14), Paul Renauer(12), Lei Peng(10), Luojia Yang(10), Zhenhao Fang(9), Paul Clark(7), Craig B. Wilen(7), Jonathan J. Park(7), Ping Ren(6), Kazushi Suzuki(4), Andrew McNamara(4), Yueqi Zhang(4), Meizhu Bai(4), Stanley Z. Lam(4), Lupeng Ye(4), Xiaoyu Zhou(4), Renata B. Filler(3), Qiancheng Xiong(3), Chenxiang Lin(3), Nathan D. Grubaugh(3)